SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C. — Lobbying Disclosure | Poliscope

SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

View full entity profile (contributions, contracts, SEC) →

This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.

Lobbying Spend

$16.7M

Filings

27

Firms Hired

1

Active Period

1999–2009

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2009	$2,380,000	5	1
2008	$2,070,000	4	1
2007	$2,160,000	2	1
2006	$2,620,000	3	1
2005	$2,060,000	3	1
2004	$1,540,000	2	1
2003	$1,850,000	3	1
2002	$940,000	1	1
2001	$700,000	2	1
2000	$300,000	1	1
1999	$100,000	1	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.	$16,720,000	27

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	24
SENATE	24
Centers For Medicare and Medicaid Services (CMS)	2
Commerce, Dept of (DOC)	2
Patent & Trademark Office (PTO)	2
Treasury, Dept of	2
Defense, Dept of (DOD)	1
Health & Human Services, Dept of (HHS)	1
Veterans Affairs, Dept of (VA)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	26
Medicare/Medicaid	Medicare/Medicaid	24
Copyright/Patent/Trademark	Copyright/Patent/Trademark	20
Animals	Animals	14
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	14
Labor Issues/Antitrust/Workplace	Labor Issues/Antitrust/Workplace	11
Trade (domestic/foreign)	Trade (domestic/foreign)	9
Agriculture	Agriculture	8
Budget/Appropriations	Budget/Appropriations	4
Veterans	Veterans	3
Pharmacy	Pharmacy	2
Advertising	Advertising	2
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	2

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 759110th Congress

To redesignate the Ellis Island Library on the third floor of the Ellis Island Immigration Museum, located on Ellis Island in New York Harbor, as the "Bob Hope Memorial Library".

2009 · fourth_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.

Client expense: $330,000 · Firm income: —

Matched citations: H.R.759

H.R. 1260111th Congress

Patent Reform Act of 2009

2009 · fourth_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.

Client expense: $330,000 · Firm income: —

Matched citations: H.R.1260

H.R. 1298111th Congress

Pharmaceutical Market Access and Drug Safety Act of 2009

2009 · fourth_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.

Client expense: $330,000 · Firm income: —

Matched citations: H.R.1298

H.R. 1427111th Congress

Promoting Innovation and Access to Life-Saving Medicine Act

2009 · fourth_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.

Client expense: $330,000 · Firm income: —

Matched citations: H.R.1427

Show 21 more cited filings

H.R. 1548111th Congress

Pathway for Biosimilars Act

2009 · fourth_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.

Client expense: $330,000 · Firm income: —

Matched citations: H.R.1548

H.R. 3200111th Congress

America's Affordable Health Choices Act of 2009

2009 · fourth_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.

Client expense: $330,000 · Firm income: —

Matched citations: H.R. 3200

H.R. 759111th Congress

Food and Drug Administration Globalization Act of 2009

2009 · fourth_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.

Client expense: $330,000 · Firm income: —

Matched citations: H.R.759

S. 260111th Congress

A bill to amend the Internal Revenue Code of 1986 to provide for the taxation of income of controlled foreign corporations attributable to imported property.

2009 · fourth_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

S.260. Legislative proposals regarding taxation of income of US corporations earned overseas: S.260.

Client expense: $330,000 · Firm income: —

Matched citations: S.260

S. 369111th Congress

Preserve Access to Affordable Generics Act

2009 · fourth_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.

Client expense: $330,000 · Firm income: —

Matched citations: S.369

S. 515111th Congress

Patent Reform Act of 2009

2009 · fourth_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.

Client expense: $330,000 · Firm income: —

Matched citations: S.515

S. 525111th Congress

Pharmaceutical Market Access and Drug Safety Act of 2009

2009 · fourth_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.

Client expense: $330,000 · Firm income: —

Matched citations: S.525

S. 610111th Congress

Patent Reform Act of 2009

2009 · fourth_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.

Client expense: $330,000 · Firm income: —

Matched citations: S.610

S. 726111th Congress

Promoting Innovation and Access to Life-Saving Medicine Act

2009 · fourth_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.

Client expense: $330,000 · Firm income: —

Matched citations: S.726

H.R. 759110th Congress

To redesignate the Ellis Island Library on the third floor of the Ellis Island Immigration Museum, located on Ellis Island in New York Harbor, as the "Bob Hope Memorial Library".

2009 · third_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.

Client expense: $330,000 · Firm income: —

Matched citations: H.R.759

H.R. 1260111th Congress

Patent Reform Act of 2009

2009 · third_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.

Client expense: $330,000 · Firm income: —

Matched citations: H.R.1260

H.R. 1298111th Congress

Pharmaceutical Market Access and Drug Safety Act of 2009

2009 · third_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.

Client expense: $330,000 · Firm income: —

Matched citations: H.R.1298

H.R. 1427111th Congress

Promoting Innovation and Access to Life-Saving Medicine Act

2009 · third_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.

Client expense: $330,000 · Firm income: —

Matched citations: H.R.1427

H.R. 1548111th Congress

Pathway for Biosimilars Act

2009 · third_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.

Client expense: $330,000 · Firm income: —

Matched citations: H.R.1548

H.R. 3200111th Congress

America's Affordable Health Choices Act of 2009

2009 · third_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.

Client expense: $330,000 · Firm income: —

Matched citations: H.R. 3200

H.R. 759111th Congress

Food and Drug Administration Globalization Act of 2009

2009 · third_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.

Client expense: $330,000 · Firm income: —

Matched citations: H.R.759

S. 260111th Congress

A bill to amend the Internal Revenue Code of 1986 to provide for the taxation of income of controlled foreign corporations attributable to imported property.

2009 · third_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

S.260. Legislative proposals regarding taxation of income of US corporations earned overseas: S.260.

Client expense: $330,000 · Firm income: —

Matched citations: S.260

S. 369111th Congress

Preserve Access to Affordable Generics Act

2009 · third_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.

Client expense: $330,000 · Firm income: —

Matched citations: S.369

S. 515111th Congress

Patent Reform Act of 2009

2009 · third_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.

Client expense: $330,000 · Firm income: —

Matched citations: S.515

S. 525111th Congress

Pharmaceutical Market Access and Drug Safety Act of 2009

2009 · third_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1, American Recovery and Reinvestment Act of 2009; H.R.2, Children's Health Insurance Program Reauthorization Act of 2009; H.R.759, Food & Drug Administration Globalization Act of 2007; H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to FDA oversight of drugs produced internationally: H.R.759, Food & Drug Administration Globalization Act of 2009. Legislative proposals permitting importation of prescription drugs from overseas: H.R.1298, Pharmaceutical Market Access and Drug Safety Act of 2009; S.525, Pharmaceutical Market Access and Drug Safety Act of 2009. Legislative proposals related to comparative effectiveness review: H.R.1, American Recovery and Reinvestment Act of 2009. Legislative proposals regarding health coverage: H.R.2, Pharmaceutical Market Access and Drug Safety Act of 2009. Response to congressional investigation regarding ENHANCE study.

Client expense: $330,000 · Firm income: —

Matched citations: S.525

S. 610111th Congress

Patent Reform Act of 2009

2009 · third_quarter · Firm: SCHERING-PLOUGH LEGISLATIVE RESOURCES L.L.C.

Open original LDA filing ↗

Cited source text and reported amounts

H.R.1260, Patent Reform Act of 2009; H.R.1427, Promoting Innovation and Access to Life Saving Medicare Act; H.R.1548, Pathway for Biosimilars Act; H.R. 3200, America's Health Choice Act; S.369, Preserve Access to Affordable Generics Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S.726, Promoting Innovation and Access to Life Saving Medicine Act; S._ _ _ (no number yet assigned), America's Health Choice Act. Legislative proposals effecting US patent system: H.R.1427, Promoting Innovations and Access to Life Saving Medicine Act; H.R.1548, Pathway for Biosimilars Act; S.726, Promoting Innovations and Access to Life Saving Medicine Act. Legislative proposals regarding follow-on biologics: H.R.1260, Patent Reform Act of 2009; H.R., 3200 America's Health Choice Act; S.515, Patent Reform Act of 2009; S.610, Patent Reform Act of 2009; S. _ _ _ (no number assigned yet), America's Health Choice Act. Legislative proposals regarding brand-generic drug firm agreements: S.369, Preserve Access to Affordable Generics Act.

Client expense: $330,000 · Firm income: —

Matched citations: S.610

Source: Senate LDA